Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SGX:T14
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SGX:T14
|
CN |
|
XTRA Bitcoin Inc
OTC:CBTC
|
US |
|
Maezawa Industries Inc
TSE:6489
|
JP |
|
America Movil SAB de CV
NYSE:AMX
|
MX |
|
Neogenomics Inc
NASDAQ:NEO
|
US |
|
R
|
Radio Fuels Energy Corp
CNSX:CAKE
|
CA |
|
C
|
Carozzi SA
SGO:CAROZZI
|
CL |
|
Tali Digital Ltd
ASX:TD1
|
AU |
|
P
|
PCC Exol SA
WSE:PCX
|
PL |
|
Breville Group Ltd
ASX:BRG
|
AU |
|
Abb Ltd
OTC:ABLZF
|
CH |
|
G
|
GCCP Resources Ltd
SGX:41T
|
MY |
|
M
|
Mediterranean Towers Ltd
TASE:MDTR
|
IL |
Dividends
Dividend Yield
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
T14 have
increased
by 290%.
Payout Ratio
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for T14 is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
T14 Price
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
| Average Annual Return | 80.01% |
| Standard Deviation of Annual Returns | 128.77% |
| Max Drawdown | -13% |
| Market Capitalization | 31.7B USD |
| Shares Outstanding | 1 427 650 099 |
| Percentage of Shares Shorted |
N/A
|
T14 Return Decomposition
Main factors of price return
Stock Splits
T14's latest stock split occurred on Jun 30, 2010
The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.
The adjusted shares began trading on Jun 30, 2010. This was the only stock split in T14's history.
